carcinoma

The GenoCTC isolation kit isolates epithelial cell adhesion molecule-positive cells from liquid biopsies and was cleared as a reagent for an IVD device.

The company plans to commercialize a gene expression signature to predict recurrence risk in cutaneous squamous cell carcinoma.

Following validation, the approach, which uses a deep convolutional neural network trained with almost 130,000 clinical images, could be developed into a smartphone app to detect skin cancer early.